RHY — Rhythm Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- AU$26.16m
- AU$24.94m
- AU$0.23m
Annual cashflow statement for Rhythm Biosciences, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | AAS | AAS | AAS | AAS | AAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.43 | 0.841 | 1.18 | 2.45 | 3.32 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.94 | -2.74 | -5.4 | -6.5 | -6.96 |
| Capital Expenditures | -0.11 | -0.046 | -0.068 | -0.027 | -0.099 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.11 | -0.046 | -0.068 | -0.027 | -0.099 |
| Financing Cash Flow Items | 0 | — | -0.225 | -0.468 | -0.024 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | -0.142 | 5.9 | 11.8 | 3.63 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.05 | -2.93 | 0.43 | 5.32 | -3.43 |